Bank of New York Mellon’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.19M Buy
689,980
+8,289
+1% +$92.5K ﹤0.01% 2217
2026
Q1
$8.11M Sell
681,691
-10,952
-2% -$112K ﹤0.01% 2043
2025
Q4
$6.9M Sell
692,643
-44,175
-6% -$422K ﹤0.01% 2134
2025
Q3
$6.59M Buy
736,818
+10,519
+1% +$97.4K ﹤0.01% 2167
2025
Q2
$6.85M Sell
726,299
-14,043
-2% -$124K ﹤0.01% 2097
2025
Q1
$8.03M Sell
740,342
-18,960
-2% -$191K ﹤0.01% 1967
2024
Q4
$7.23M Buy
759,302
+14,378
+2% +$146K ﹤0.01% 2096
2024
Q3
$8.37M Sell
744,924
-1,287
-0.2% -$13.7K ﹤0.01% 2026
2024
Q2
$7.46M Buy
746,211
+20,599
+3% +$209K ﹤0.01% 2121
2024
Q1
$8.35M Sell
725,612
-12,714
-2% -$108K ﹤0.01% 2047
2023
Q4
$5.38M Buy
738,326
+85,266
+13% +$672K ﹤0.01% 2327
2023
Q3
$5.94M Buy
653,060
+25,963
+4% +$311K ﹤0.01% 2223
2023
Q2
$7.63M Sell
627,097
-19,076
-3% -$213K ﹤0.01% 2087
2023
Q1
$8.03M Sell
646,173
-19,083
-3% -$351K ﹤0.01% 2038
2022
Q4
$12.8M Sell
665,256
-33,458
-5% -$707K ﹤0.01% 1795
2022
Q3
$13.1M Buy
698,714
+413,014
+145% +$8.49M ﹤0.01% 1734
2022
Q2
$5.15M Sell
285,700
-105,334
-27% -$1.71M ﹤0.01% 2277
2022
Q1
$6.27M Sell
391,034
-4,718
-1% -$84.8K ﹤0.01% 2302
2021
Q4
$9.68M Buy
395,752
+36,665
+10% +$861K ﹤0.01% 2121
2021
Q3
$8.36M Buy
359,087
+8,258
+2% +$200K ﹤0.01% 2225
2021
Q2
$9.62M Sell
350,829
-1,416,676
-80% -$40.4M ﹤0.01% 2164
2021
Q1
$65M Buy
1,767,505
+982
+0.1% +$34.7K 0.01% 937
2020
Q4
$66.3M Sell
1,766,523
-128,359
-7% -$3.97M 0.01% 880
2020
Q3
$41.3M Buy
1,894,882
+825,468
+77% +$17.3M 0.01% 1030
2020
Q2
$17.2M Buy
1,069,414
+495,014
+86% +$8.27M ﹤0.01% 1534
2020
Q1
$9.19M Buy
+574,400
New +$8.12M ﹤0.01% 1748

Other funds holding AHCO

Bank of New York Mellon's AHCO Position: Q2 2026 in Review

Bank of New York Mellon increased its AdaptHealth (AHCO) stake by 1.2% in Q2 2026, buying an estimated $92.5K and bringing the position to 689,980 shares worth $7.19M. The position accounts for ﹤0.01% of the portfolio, ranked #2217.

Bank of New York Mellon first reported a position in AHCO in Q1 2020 and has held it in 26 quarters since. The position peaked at $66.3M in Q4 2020. 123 funds tracked by Wall St. Rank hold AHCO as of Q2 2026.

  • Bank of New York Mellon held 689,980 shares of AdaptHealth worth $7.19M as of Q2 2026.
  • Bank of New York Mellon bought 8,289 AdaptHealth shares in Q2 2026, an estimated $92.5K.
  • AdaptHealth made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2217 holding.
  • Bank of New York Mellon first reported a position in AdaptHealth in Q1 2020 and has held it in 26 quarters since.
  • Bank of New York Mellon's AdaptHealth position peaked at $66.3M in Q4 2020.
  • 123 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.